PerkinElmer Inc
Most Recent
Here’s What Varian Medical Systems’ Valuation Trend Indicates
Of the nine analysts covering Varian Medical Systems (VAR) stock, three have given it a “strong buy,” three have given it a “hold,” and three have given it a “sell.”
Thermo Fisher Scientific Accelerates Its Semiconductor Sequencing
On June 29, 2017, Thermo Fisher Scientific (TMO) announced the addition of three new products to its semiconductor failure analysis workflows portfolio.
What Bio-Rad Laboratories Expects from Life Science
In 1Q17, Bio-Rad Laboratories’ (BIO) Life Science segment reported revenues of ~$174.3 million, which represents a YoY rise of ~5.1%.
Inside Bio-Rad Laboratories’ Profit Margin Expectations in 2017
On March 13, 2017, Bio-Rad Laboratories (BIO) announced that it expects to reach an EBITDA margin of around 20% by 2020.
Inside Bio-Rad Laboratories’ Robust Revenue Growth Projection for 2017
On March 13, 2017, Bio-Rad Laboratories (BIO) provided a long-term, currency-neutral revenue growth target of around 3%–5%.
Bio-Rad Laboratories on the Street: Analysts’ Recommendations in May
In 1Q17, Bio-Rad Laboratories (BIO) reported revenues of ~$500.1 million, which represented a YoY (year-over-year) rise of around 6.1%.
XLV’s Mid Caps Underperform SPY
PerkinElmer went down by 3.1% to close at $48.58 and was trading just below the 20-day moving average.
XLV Mid-Cap Stocks Witness Profit-Booking
The mid-cap stocks of the Health Care Select Sector SPDR ETF (XLV) fell collectively by 2.6%. They underperformed XLV as of March 8, 2016.
Waters Led XLV’s Electronic Subgroup
Waters closed at $133.73 and was trading above its 100-day moving average price of $126.45, and it was also trading above its 20-day moving average price of $131.44.
Tenet Is the Only XLV Mid-Cap Stock with Positive Returns
With a return of 0.15%, Tenet Healthcare (THC) was the only stock among XLV’s mid caps that gave a positive return on December 9.
How PerkinElmer Topped the XLV’s Mid-Cap Stocks
At the Stifel 2015 Healthcare Conference, PerkinElmer presented its current position as well as its future growth and strategies for different markets.
Service Sector Expanded at Faster Rate in October
The service sector makes up more than 85% of the US economy. With manufacturing picking up in October, faster growth in the service sector may further ramp up economic growth.
Patterson Companies Was XLV’s Worst Performer
Patterson Companies was the worst performer within the Health Care Select Sector SPDR ETF (XLV) for the period between August 25 and August 31, with a return of -4.10%.
PerkinElmer and Mallinckrodt Help Bottom Ten Stocks in XLV
PerkinElmer (PKI) with a return of 5.94% was the best performer of XLV’s bottom ten stocks.